Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Aslan Pharmaceuticals
Pharma
Hengrui, Sanofi and Aslan—Fierce Pharma Asia
Hengrui got an FDA warning letter. Sanofi invests in its global capacity center in India. Singapore biotech Aslan Pharma winds down.
Angus Liu
Jul 19, 2024 9:48am
AZ-Daiichi, Moderna, Takeda and more—Fierce Pharma Asia
Jul 7, 2023 9:45am
China's NRDL, Biocon-Viatris and more—Fierce Pharma Asia
Dec 10, 2021 8:45am
AstraZeneca, Pfizer-BioNTech, Legend and more—FiercePharmaAsia
Aug 7, 2020 10:20am
Remdesivir, Indian pharmas, CanSino and more—FiercePharmaAsia
Apr 17, 2020 10:48am
Gilead, Aurobindo-Spectrum and more—FiercePharmaAsia
Jan 18, 2019 10:29am
